S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
NASDAQ:TRUP

Trupanion (TRUP) Stock Price, News & Analysis

$22.45
+1.09 (+5.10%)
(As of 04/19/2024 ET)
Today's Range
$21.37
$22.87
50-Day Range
$21.36
$35.28
52-Week Range
$18.45
$37.71
Volume
932,517 shs
Average Volume
682,567 shs
Market Capitalization
$938.63 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$33.20

Trupanion MarketRank™ Stock Analysis

Analyst Rating
Hold
2.25 Rating Score
Upside/​Downside
47.9% Upside
$33.20 Price Target
Short Interest
Bearish
40.35% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.61
Upright™ Environmental Score
News Sentiment
0.53mentions of Trupanion in the last 14 days
Based on 11 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.43) to $0.05 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.22 out of 5 stars

Finance Sector

631st out of 848 stocks

Hospital & Medical Service Plans Industry

9th out of 11 stocks

TRUP stock logo

About Trupanion Stock (NASDAQ:TRUP)

Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. Trupanion, Inc. was founded in 2000 and is headquartered in Seattle, Washington.

TRUP Stock Price History

TRUP Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Trupanion Inc
Dog bless you
Analyzing NeueHealth (NYSE:NEUE) & Trupanion (NASDAQ:TRUP)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Trupanion Publishes 2023 Annual Letter to Shareholders
Texas pets are feeling allergy season
Trupanion, Inc.'s (NASDAQ:TRUP) Path To Profitability
Piper Sandler Reaffirms Their Hold Rating on Trupanion (TRUP)
Spring allergies suck for pets, too
More scratchy, sniffly pets
Pet allergies on the uptick
Dog allergy reports are up
See More Headlines
Receive TRUP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trupanion and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/15/2024
Today
4/19/2024
Next Earnings (Estimated)
5/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Finance
Industry
Hospital & medical service plans
Sub-Industry
N/A
Current Symbol
NASDAQ:TRUP
Employees
1,142
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$33.20
High Stock Price Target
$47.00
Low Stock Price Target
$28.00
Potential Upside/Downside
+55.4%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
4 Analysts

Profitability

Net Income
$-44,690,000.00
Pretax Margin
-4.06%

Debt

Sales & Book Value

Annual Sales
$1.11 billion
Book Value
$7.31 per share

Miscellaneous

Free Float
39,386,000
Market Cap
$893.06 million
Optionable
Optionable
Beta
1.71
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Mr. Darryl Graham Andrew Rawlings (Age 55)
    Founder, CEO & Chair of the Board
    Comp: $300k
  • Ms. Margaret Rosemary Maria Tooth (Age 45)
    President
    Comp: $300k
  • Ms. Emily Dreyer (Age 36)
    Senior Vice President of Channel Growth
    Comp: $261.87k
  • Mr. Fawwad Qureshi
    Chief Finance Officer
  • Ms. Brenna McGibney (Age 55)
    Chief Administrative Officer
  • Ms. Laura Bainbridge
    Senior Vice President of Corporate Communications
  • Dr. Steve Weinrauch BVMS (Age 49)
    MRCVS, Executive Vice President of North America & Veterinary Strategy
  • Ms. Bradley Lamb
    Head of Conversion
  • Mr. John Gallagher (Age 37)
    Executive Vice President of Global Support Services
  • Mr. Shawn McWashington
    Head of Corporate Group Benefits

TRUP Stock Analysis - Frequently Asked Questions

Should I buy or sell Trupanion stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Trupanion in the last year. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" TRUP shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TRUP, but not buy additional shares or sell existing shares.
View TRUP analyst ratings
or view top-rated stocks.

What is Trupanion's stock price target for 2024?

4 brokerages have issued 1 year target prices for Trupanion's shares. Their TRUP share price targets range from $28.00 to $47.00. On average, they expect the company's stock price to reach $33.20 in the next year. This suggests a possible upside of 47.9% from the stock's current price.
View analysts price targets for TRUP
or view top-rated stocks among Wall Street analysts.

How have TRUP shares performed in 2024?

Trupanion's stock was trading at $30.51 at the start of the year. Since then, TRUP shares have decreased by 26.4% and is now trading at $22.45.
View the best growth stocks for 2024 here
.

When is Trupanion's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our TRUP earnings forecast
.

How were Trupanion's earnings last quarter?

Trupanion, Inc. (NASDAQ:TRUP) announced its earnings results on Thursday, February, 15th. The financial services provider reported ($0.05) EPS for the quarter, topping the consensus estimate of ($0.18) by $0.13. The financial services provider earned $295.50 million during the quarter, compared to analysts' expectations of $289.84 million. Trupanion had a negative trailing twelve-month return on equity of 15.19% and a negative net margin of 4.03%. The business's quarterly revenue was up 20.1% compared to the same quarter last year. During the same period in the previous year, the company earned ($0.23) earnings per share.

What ETFs hold Trupanion's stock?

ETFs with the largest weight of Trupanion (NASDAQ:TRUP) stock in their portfolio include ProShares Pet Care ETF (PAWZ) and iShares U.S. Insurance ETF (IAK).Noble Absolute Return ETF (NOPE).

What guidance has Trupanion issued on next quarter's earnings?

Trupanion updated its FY 2024 earnings guidance on Friday, February, 16th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.2 billion-$1.3 billion, compared to the consensus revenue estimate of $1.2 billion.

What is Darryl Rawlings' approval rating as Trupanion's CEO?

139 employees have rated Trupanion Chief Executive Officer Darryl Rawlings on Glassdoor.com. Darryl Rawlings has an approval rating of 76% among the company's employees.

What other stocks do shareholders of Trupanion own?
Who are Trupanion's major shareholders?

Trupanion's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Check Capital Management Inc. CA (0.08%). Insiders that own company stock include Andrew D Wolff, Asher Bearman, Dan Levitan, Darryl Rawlings, Gavin Friedman, Howard E Rubin, Margaret Tooth, Melissa Joy Hewitt, Michael Doak, Murray B Low, Robin A Ferracone, Steve Weinrauch and Tricia Plouf.
View institutional ownership trends
.

How do I buy shares of Trupanion?

Shares of TRUP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:TRUP) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners